Description: The presenters will share information about: -Insights into causes of death through the use of predictive models, based on a reinsured U.S. life portfolio, using logistic regression models to understand three main causes of death: cancer, heart and external causes; -Opioid abuse is a widespread phenomenon with drug-related mortality rates rising steeply in the U.S. over the past two decades. But what does the most recent data tell U.S. about the outlook for Opioid-related mortality?; -'Deaths of despair' have been publicized as a cause for the poor performance of U.S. mortality in recent years. The presenters will be looking at the different causes under this label, their evolution and explore the drivers behind them.

Description: This is a discussion of indexed coverages for individual contracts. It covers such topics as the history of indexed coverage in the U.S. and Canada and other countries and the possibilities for the ideal fully-indexed permanent life insurance and disability income plans.

Description: The presenters in this classic session will explore protection and accumulation products as well discuss the current state of the hybrid Life/LTC market. They will also examine the latest trends and the challenges to innovation and highlight key factors impacting the product actuary including the impact of technology, regulation and competitive environment. 

Description: The management of the investments of an insurance enterprise has undergone a considerable evolution since the pioneering work of Redington in the mid 20th century. Best practices have evolved to incorporate ever more complex insurance liabilities, expanding investment asset classes and global market opportunities. Strategic asset allocation (SAA), liability driven investing, and other robust optimization approaches form the core of the professional management of insurance company investments.

Description: This 1979 session is about Non-Smoker Policies. Topics covered: 1. What data are available? How significant are they? 2. What are the effects of cigarette smoking on health? 3. In what ways can people be educated to stop or not start smoking cigarettes? 4. What are the possible policy implications of the foregoing for the life and health insurance business? 5. For policies with nonsmoker discounts, what are the pricing implications with respect to: a. Nature of the discount -Should it be guaranteed? b. Effect on standard class pricing? Deficiency reserves? Reinsurance? c. Competitive impact? 6. The application form: Information needed, and how do you get it?

Description: This 1978 discussion focused on Adjustable Life Products. Topics included: 1. Current status in marketplace. 2. Future expectations. 3. Product design. 4. Typical riders. 5. Strengths and weaknesses. 6. Administrative requirements.

Description: 1994 SOA Spring Meeting, San Francisco. The panel discussed current issues in participating, UL, and non-guaranteed element products. Topics of discussion included product design, regulatory issues, implementation, pricing issues, and compensation.

Description: This 1978 session discussed ADJUSTABLE LIFE PRODUCTS including: 1. Problems encountered in the planning, development, implementation and maintenance stages. 2. Product-design features. 3. Strengths and limitations. 4. Administrative systems and procedures. 5. Pricing. 6. Nonforfeiture values and reserves. 7. Marketing. 8. Sales results.

Description: This session from the 1995 SOA Boston Meeting covers usage, sales methods, and design of COLI products and their many variations. Presenters will discuss market potential, distribution systems, risks, product features, pricing implications, and tax issues. From the Record of the Society of Actuaries, Vol. 21, No. 4b.

Description: 1999 SOA Regional Meeting, Atlanta. This session covered the process of rapid product issue and the implications that has from a marketing, underwriting, operational, product pricing, and design standpoint.